[1,2,4]triazolopyridines and their use as phosphodiesterase inhibitors
US9181248B2 · kind B2 · utility
4Cited by
0References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 16, 2014 |
| Grant date | Nov 10, 2015 |
| Priority date | — |
| Expiry date | Dec 16, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel [1,2,4]triazolopyridine compounds with phosphodiesterase inhibitory activity, as well as to their use as therapeutic agents in the treatment of inflammatory diseases and conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.